Micron Integrated Technologies

Micron Biomedical is a clinical-stage biopharmaceutical company focused on the development of needle-free, dissolvable microneedle patch technology for the delivery of vaccines and therapeutics. The company's platform is designed to improve the reach and effectiveness of medicines by eliminating the need for cold-chain storage and professional administration. Micron's lead program, a measles-rubella vaccine patch, has successfully completed Phase 1/2 clinical trials, demonstrating safety and immunogenicity comparable to traditional injections. The company partners with global health organizations like the Bill & Melinda Gates Foundation to address critical healthcare challenges in underserved regions. Their technology also holds potential for delivering small molecules and biologics across various therapeutic areas.